MacNeil A., Farnon E. C., Wamala J.
[et al.]. Proportion of deaths and clinical features in Bundibugyo Ebola virus infection, Uganda // Emerg. Infect. Dis. – 2010. – Vol. 16, № 12. – P. 1969 – 1972.Mupapa K., Mukundu W., Bwaka M. A
. [et al.]. Ebola hemorrhagic fever and pregnancy // J. Infect. Dis. – 1999. – Vol. 179, suppl. 1. – P. S11 – S12.Panning M., Emmerich P., Olschlager S.
[et al.]. Laboratory diagnosis of Lassa Fever, Liberia // Emerg Infect Dis. – 2010. – Vol. 16, № 6. – P. 1041 – 1043.Pourrut X., Kumulungui B., Wittmann T.
[et al.]. The natural history of Ebola virus in Africa // Microb. Infect. – 2005. – Vol. 7, № 7 – 8. – P. 1005 – 1014.Pourrut X., Delicat A., Rollin E.
[et al.]. Spatial and temporal patterns of Zaire ebolavirus antibody prevalence in the possible reservoir bat species // J. Infect. Dis. – 2006. – Vol. 186, suppl. 2. – P. S176 – S183.Rollin P. E., Williams R. J., Bressler D. S.
[et al.]. Ebola (subtype Reston) virus among quarantined nonhuman primates recently imported from the Philippines to the United States // J. Infect. Dis. – 1999. – Vol. 179, suppl. 1. – P. S108 – S114.Rowe A. K., Bertolli J., Khan A. S
. [et al.]. Clinical, virologic, and immunologic follow-up of convalescent Ebola hemorrhagic fever patients and their household contacts, Kikwit, Democratic Republic of the Congo. Commission de Lutte contre les Epidemies a Kikwit // J. Infect. Dis. – 1999. – Vol. 179, suppl. 1. – P. S28 – S35.Safronetz D., Lopez J. E., Sogoba N
. [et al.]. Detection of Lassa virus, Mali // Emerg. Infect. Dis. – 2010. – Vol. 16, № 7. – P. 1123 – 1126.Swanepoel R. L., Leman P. A., Burt F.J.
[et al.]. Experimental inoculation of plants and animals with Ebola virus // Emerg. Infect. Dis. – 1996. – Vol. 2, № 4. – P. 321 – 325.Swenson D. L., Wang D., Luo M.
[et al.]. Vaccine to confer to nonhuman primates complete protection against multistrain Ebola and Marburg virus infectione // Clin. Vaccine Immunol. – 2008. – Vol. 15, № 3. – P. 460 – 467.Suzuki Y., Gojobori T.
The origin and evolution of Ebola and Marburg viruses // Mol. Biol. Evol. – 1997. – Vol. 14, № 8. – P. 800 – 806.Taniguchi S., Watanabe Sh., Masangkay J.S.
[et al.]. Reston Ebolavirus antibodies in bats the Phillippines // Emer g. Infect. Dis. – 2011. – Vol. 17, № 8. – P. 1559 – 1560.Timen A., Koopmans M. P., Vossen A. C.
[et al.]. Response to imported case of Marburg Hemorrhagic Fever, the Netherland // Emerg. Infect. Dis. – 2009. – Vol. 15, № 8. – P. 1171 – 1175.Timen A., Isken L. D., Willemse P.
[et al.]. Retrospective evaluation of control measures for contacts of patients with Marburg hemorrhagic fever // Emerg. Infect. Dis. – 2012. – Vol. 18, № 7. – P. 1107 – 1114.Towner J. S., Amman B. R., Sealy T. K. [et al.].
Isolation of genetically diverse Marburg viruses from Egyptian fruit bats // PLoS Pathog. – 2009. – Vol. 5, № 7. – e1000536.Turell M. J., Bressler D.S., Rossi C. A.
Short report: lack of virus replication in arthropods after intrathoracic inoculation of Ebola Reston virus // Am. J. Trop. Med. Hyg. – 1996. – Vol. 55, № 1. – P. 89 – 90.Viral Hemorrhagic fever surveillance: Marburg and Ebola Disease // WHO Weekly Epidemiol. Records. – 1984. – Vol. 39. – P. 300 – 301.
Wamala J. F., Lukwago L., Malimbo M
. [et al.]. Ebola hemorrhagic fever associated with novel virus strain, Uganda, 2007 – 2008 // Emerg. Infect. Dis. – 2010. – Vol. 16, № 7. – P. 1087 – 1092.Weingartl H. M., Embury-Hyatt C., Nfon C
. [et al.]. Transmission of Ebola virus from pigs to non-human primates // Sci. Rep. – 2012. – Vol. 2. – P. 811. WER. Ebolа virus // Weekly Epidemiol. Rec. – 1990. – Vol. 65, № 7. – P. 45 – 47.
Рис. 2.
Геморрагические проявления при желтой лихорадке
Рис. 4
. Географическое распространение лихорадки денге
Рис. 9.
Павшая лошадь от ЛЗН
Рис. 12.
Динамика заболеваемости ЛЗН в Греции и Македонии по неделям 2010 г.
Рис. 14
. Территориальное распределение заболеваний ККГЛ с 1999 по 2009 г.
Рис. 18.
Геморрагические проявления при лихорадке Эбола
Рис. 21
. Распространение лихорадки Ласса